Loading...
Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges
Drug discovery and development has become longer and costlier process. The fear of failure and stringent regulatory review process is driving pharmaceutical companies towards “me too” drugs and improved generics (505(b) (2)) fillings. The discontinuance of molecules at late stage clinical trials is...
Saved in:
| Published in: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4590717/ https://ncbi.nlm.nih.gov/pubmed/26579359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2013.12.003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|